CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents.
Options
BORIS DOI
Publisher DOI
PubMed ID
40016301
Date of Publication
2025-04
Publication Type
Article
Subject(s)
600 - Technology::610 - Medicine & health
Language(s)
en
Contributor(s)
Reuvekamp, Tom | |
Ngai, Lok Lam | |
den Hartog, Daphne | |
Carbaat-Ham, Jannemieke | |
Fayed, Mona M H E | |
Scholten, Willemijn J | |
Mocking, Tim R | |
Chitu, Dana A | |
Klein, Saskia K | |
Stussi, Georg | |
Griskevicius, Laimonas | |
Breems, Dimitri | |
van Lammeren-Venema, Danielle | |
Boersma, Rinske | |
Ossenkoppele, Gert J | |
van de Loosdrecht, Arjan A | |
Bachas, Costa | |
Huls, Gerwin | |
de Leeuw, David C | |
Cloos, Jacqueline |
Additional Credits
Clinic of Medical Oncology
Series
Leukemia
Publisher
Springer Nature [academic journals on nature.com]
ISSN
1476-5551
0887-6924
Access(Rights)
open.access